Cortical Labs has unveiled CL1, a groundbreaking biological computing platform that enables researchers to deploy code directly to living neurons. The system merges lab-grown human neurons with silicon-based hardware, introducing a new paradigm in computing known as Synthetic Biological Intelligence (SBI) and opening the door to next-generation research in neuroscience, artificial intelligence, and biomedical innovation.
CL1 is designed as the world’s first code-deployable biological computer, combining biological neural networks with custom silicon chips to create a hybrid system capable of processing information in ways that traditional digital computers cannot. Unlike conventional AI systems that simulate neural behavior, the CL1 platform works with real neurons cultivated on a silicon substrate, allowing them to receive and respond to electrical signals in real time.
Through the company’s Biological Intelligence Operating System (biOS), researchers can program and interact with these neural networks in a closed-loop environment where neurons respond to stimuli, adapt, and influence digital systems dynamically. The platform allows scientists and developers to test how biological neurons process information and learn from inputs, offering a radically different approach to intelligence compared with conventional machine learning models.
The CL1 platform integrates a complete life-support system designed to maintain the health and viability of the neurons for extended experimentation. Within the unit, temperature, gas exchange, and nutrient flow are regulated to sustain neural cultures while electrical interfaces continuously record and stimulate neuronal activity. This self-contained design eliminates the need for external computing infrastructure, enabling researchers to run experiments and deploy applications directly on the device.
Beyond being a standalone system, CL1 can also operate as part of a scalable biological computing infrastructure. Multiple units can be assembled into server racks, enabling larger-scale neural network experimentation and integration with cloud platforms. This architecture allows institutions to conduct distributed experiments and collaborate remotely using a shared biological computing environment.
Also Read: Exact Sciences Stockholders Approve Abbott Acquisition
The platform has the potential to significantly accelerate scientific discovery across multiple industries. By enabling direct interaction with living neural networks, researchers can gain deeper insights into neurological diseases, cognitive processes, and the effects of pharmaceutical compounds on brain cells. This capability may support faster drug discovery, improved disease modeling, and more accurate studies of neurological conditions such as Alzheimer’s and Parkinson’s disease.
In addition to medical applications, CL1 represents a new direction for artificial intelligence and computing research. Biological neural networks possess natural learning and adaptability capabilities developed through billions of years of evolution, offering the potential for faster learning and greater efficiency than purely digital systems. The hybrid biological-silicon approach could therefore inspire entirely new computational architectures that require significantly less energy than traditional AI infrastructures.
To further expand accessibility, Cortical Labs is developing a cloud-based model that allows researchers to interact with neural systems remotely without maintaining their own cell-culture facilities. This “wetware-as-a-service” approach is designed to provide scientists, developers, and organizations worldwide with access to biological computing resources through a shared platform.
“This platform will enable the millions of researchers, innovators and big thinkers around the world to turn the CL1’s potential into tangible, real-word impact. We’ll provide the platform and support for them to invest in R&D and drive new breakthroughs and research.” Dr Hon Weng Chong, Founder and CEO, Cortical Labs.
Building on years of research in neural computing and earlier demonstrations of neurons learning tasks such as playing video games, CL1 represents a major milestone in the convergence of biology and technology. By making biological computing accessible to researchers and innovators, Cortical Labs aims to usher in a new era of computing where living neural networks and digital systems work together to solve some of the world’s most complex scientific challenges.
Source: Cortical Labs
